Adenocarcinoma of the Pancreas Recruiting Phase 2 Trials for Ceritinib (DB09063)

Also known as: Pancreatic adenocarcinoma / Adenocarcinoma Pancreas / Pancreas, Adenocarcinoma / Pancreas Adenocarcinoma / Adenocarcinoma of Pancreas / Adenocarcinoma, Pancreas

IndicationStatusPhase
DBCOND0029532 (Adenocarcinoma of the Pancreas)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02638909Study of Oral Ceritinib in Patients With ALK and ROS1 Activated Gastrointestinal MalignanciesTreatment